Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease (vol 363, 114370, 2023)

被引：0

作者：

Corsi, Sara ^{[1
]}

Scheggi, Simona ^{[2
]}

Pardu, Alessandra ^{[1
]}

Braccagni, Giulia ^{[2
]}

Caruso, Donatella ^{[3
]}

Cioffi, Lucia ^{[2
]}

Diviccaro, Silvia ^{[3
,4
]}

Gentile, Mauro ^{[1
]}

Fanni, Silvia ^{[1
]}

Stancampiano, Roberto ^{[1
]}

Gambarana, Carla ^{[2
]}

Melcangi, Roberto Cosimo ^{[3
]}

Frau, Roberto ^{[1
,5
]}

Carta, Manolo ^{[1
]}

机构：

[1] Univ Cagliari, Dept Biomed Sci, Cagliari, CA, Italy

[2] Univ Siena, Dept Mol & Dev Med, Siena, SI, Italy

[3] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, MI, Italy

[4] Lund Univ, Basal Gangl Pathophysiol Unit, Dept Expt Med Sci, Lund, Sweden

[5] Univ Cagliari, Guy Everett Lab, Dept Biomed Sci, Cagliari, Italy

来源：

EXPERIMENTAL NEUROLOGY | 2024年 / 373卷

关键词：

D O I：

10.1016/j.expneurol.2023.114640

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页数：1

共 50 条

[41] Impaired cognitive and motor function are coincident with l-DOPA-induced dyskinesia in a model of Parkinson’s disease
Mariah J. Lelos
Ellen M. Murphy
Hanna S. Lindgren
Stephen B. Dunnett
Emma L. Lane
Scientific Reports, 13
[42] The Role of Norepinephrine Neurons in Motor Symptoms of Parkinson's Disease and Development of L-DOPA-Induced Dyskinesia
Shin, E.
Bjorklund, A.
Carta, M.
MOVEMENT DISORDERS, 2010, 25 : S634 - S635
[43] Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
M. A. Cenci
Amino Acids, 2002, 23 : 105 - 109
[44] Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
Nilson Carlos Ferreira Junior
Maurício dos- Santos-Pereira
Francisco Silveira Guimarães
Elaine Del Bel
Neurotoxicity Research, 2020, 37 : 12 - 29
[45] The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
Vidailhet, M
Bonnet, AM
Marconi, R
Durif, F
Agid, Y
MOVEMENT DISORDERS, 1999, 14 : 13 - 18
[46] Impaired cognitive and motor function are coincident with l-DOPA-induced dyskinesia in a model of Parkinson's disease
Lelos, Mariah J.
Murphy, Ellen M.
Lindgren, Hanna S.
Dunnett, Stephen B.
Lane, Emma L.
SCIENTIFIC REPORTS, 2023, 13 (01)
[47] Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
Cenci, MA
AMINO ACIDS, 2002, 23 (1-3) : 105 - 109
[48] Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
Park, Hye-Yeon
Ryu, Young-Kyoung
Kim, Yong-Hoon
Park, Tae-Shin
Go, Jun
Hwang, Jung Hwan
Choi, Dong-Hee
Rhee, Myungchull
Lee, Chul-Ho
Kim, Kyoung-Shim
NEUROBIOLOGY OF DISEASE, 2016, 89 : 169 - 179
[49] Serotonergic targets for the treatment of L-DOPA-induced dyskinesia
Lanza, Kathryn
Bishop, Christopher
JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (08) : 1203 - 1216
[50] Serotonergic targets for the treatment of l-DOPA-induced dyskinesia
Kathryn Lanza
Christopher Bishop
Journal of Neural Transmission, 2018, 125 : 1203 - 1216

← 1 2 3 4 5 →